These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 4710040)

  • 1. Suppressed development of cytotoxic lymphoid cells in tumor-immunized mice.
    Martin WJ; Wunderlich JR; Macdonald J
    Isr J Med Sci; 1973 Mar; 9(3):324-31. PubMed ID: 4710040
    [No Abstract]   [Full Text] [Related]  

  • 2. Evidence for the suppression of the development of cytotoxic lymphoid cells in tumor immunized mice.
    Martin WJ; Esber E; Wunderlich JR
    Fed Proc; 1973 Feb; 32(2):173-9. PubMed ID: 4688656
    [No Abstract]   [Full Text] [Related]  

  • 3. Functional efficiency of antitumor cytotoxic lymphoid cells.
    Wunderlich JR; Martin WJ; Macdonald J
    Isr J Med Sci; 1973 Mar; 9(3):317-23. PubMed ID: 4710039
    [No Abstract]   [Full Text] [Related]  

  • 4. Functional capacity of cytotoxic lymphoid cells.
    Wunderlich JR; Martin WJ; Macdonald J; Fletcher F
    Natl Cancer Inst Monogr; 1972 Dec; 35():243-9. PubMed ID: 4676543
    [No Abstract]   [Full Text] [Related]  

  • 5. Induction of lymphocyte-mediated cytotoxicity against allogeneic tumor cells by concanavalin A in vivo.
    Anaclerio A; Waterfield JD; Möller G
    J Immunol; 1974 Sep; 113(3):870-5. PubMed ID: 4413847
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunity to lymphoid tumors in syngeneic mice by immunization with mitomycin C-treated cells.
    Benjamini E; Fong S; Erickson C; Leung CY; Rennick D; Scibienski RJ
    J Immunol; 1977 Feb; 118(2):685-93. PubMed ID: 839074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of irradiated and mitomycin-treated mouse spleen cells as stimulating cells in mixed lymphocyte cultures and in vitro sensitization.
    Hodes RJ; Terry WD
    J Immunol; 1974 Jul; 113(1):39-44. PubMed ID: 4275549
    [No Abstract]   [Full Text] [Related]  

  • 8. Mechanism of blocking by hyperimmune serum of lymphocyte-mediated cytolysis of allogeneic tumor cells.
    Todd RF; Stulting RD; Berke G
    Cancer Res; 1973 Dec; 33(12):3203-8. PubMed ID: 4760536
    [No Abstract]   [Full Text] [Related]  

  • 9. Circulation of lymphoid cells in mice infected with Friend leukemia virus.
    Bainbridge DR; Bendinelli M
    J Natl Cancer Inst; 1972 Sep; 49(3):773-81. PubMed ID: 4539617
    [No Abstract]   [Full Text] [Related]  

  • 10. Temperature control of lymphocyte-mediated cytotoxicity in vitro.
    Berke G; Sullivan KA
    Transplant Proc; 1973 Mar; 5(1):421-3. PubMed ID: 4695950
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cytotoxic lymphocytes and anti-tumor immunity].
    Cerottini JC; Brunner KT
    Ann Inst Pasteur (Paris); 1972 Apr; 122(4):659-68. PubMed ID: 4403239
    [No Abstract]   [Full Text] [Related]  

  • 12. Immune response to an allogeneic progressively growing solid tumor.
    Eggers AE
    Cancer Res; 1976 Jun; 36(6):2085-9. PubMed ID: 773534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of macrophages in tumour immunity. I. Co-operation between macrophages and lymphoid cells in syngeneic tumour immunity.
    Evans R; Alexander P
    Immunology; 1972 Oct; 23(4):615-26. PubMed ID: 5084104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 51 Chromium-release assay for cell-mediated cytotoxicity of human leukemia and lymphoid tissue-culture cells.
    McCoy JL; Herberman RB; Rosenberg EB; Donnelly FC; Levine PH; Alford C
    Natl Cancer Inst Monogr; 1973 Jun; 37():59-67. PubMed ID: 4123455
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative immunogenicity of various cellular and cell-free preparations in a leukemia isotransplant system.
    Tennant JR; Kingsley S
    J Natl Cancer Inst; 1971 Nov; 47(5):953-60. PubMed ID: 4330801
    [No Abstract]   [Full Text] [Related]  

  • 16. Cell-mediated immune responses in vitro. I. Suppression of the generation of cytotoxic lymphocytes by concanavalin A and concanavalin A-activated spleen cells.
    Peavy DL; Pierce CW
    J Exp Med; 1974 Aug; 140(2):356-69. PubMed ID: 4276949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies of inhibition of tumour cell DNA synthesis by immune cells in Gross virus induced leukemia.
    Finklestein JZ; Byfield J; Tittle K; Imagawa DT
    Rev Eur Etud Clin Biol; 1972 Mar; 17(3):287-92. PubMed ID: 5053619
    [No Abstract]   [Full Text] [Related]  

  • 18. Production of tumor-specific antibody in the xenogeneic host: use of blocking antibody.
    Weiner RS; Hubbard JD; Mardiney MR
    J Natl Cancer Inst; 1972 Oct; 49(4):1063-70. PubMed ID: 4117316
    [No Abstract]   [Full Text] [Related]  

  • 19. Modulation of the immune response to transplantation antigens. I. The effects of immunization using adjuvants on the immune response of mice to a tumour allograft.
    Zola H
    Clin Exp Immunol; 1972 Aug; 11(4):585-93. PubMed ID: 4563711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppressive effect of concanavalin-A. II. In vivo suppression of cytotoxic lymphocytes generation in alloimmunized mice.
    Wasik M; Skopińska E
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):331-3. PubMed ID: 749783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.